TE_10676
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 402.37 |
| Counts of samples | TCGA_tumor:356; TCGA_normal:0; GTEx:0 |
| TSS | chr4(+):68515444 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_10676.11 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68521135,68521280,68535619,68535639 |
| teRNA_10676.12 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68521135,68521280,68535653,68535811,68537066,68538007,68551045,68551065 |
| teRNA_10676.13 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537066,68537086 |
| teRNA_10676.14 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537066,68538007,68550997,68551017 |
| teRNA_10676.15 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537066,68538007,68539810,68539830 |
| teRNA_10676.16 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537090,68538007,68539810,68539830 |
| teRNA_10676.17 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537090,68537110 |
| teRNA_10676.18 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537066,68538007,68539806,68539826 |
| teRNA_10676.19 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68535653,68535811,68537066,68538007,68551479,68551499 |
| teRNA_10676.20 | - | Intergenic | Non-coding | Non-coding | chr4(+):68515445,68515572,68550997,68551073,68551479,68551499 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
